Arcutis Biotherapeutics CEO Executes Stock Sale Amid Mixed Quarterly Financial Results
Todd Watanabe, the President and Chief Executive Officer of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), has completed a sale of company stock. On May 4, 2026, Watanabe sold 3,172 shares of common stock, a transaction that yielded approximately $74,892. The shares were traded at prices ranging from a low of $23.16 to a high of $23.93, resulting in …